SHE: 000989

Company Drug

Jiuzhitang’s Stem Cell Therapy for Autism Receives NMPA Clinical Trial Approval

Fineline Cube Mar 13, 2025

China-based Jiuzhitang Co. Ltd (SHE: 000989) announced receiving clinical trial approval from the National Medical...

Company Drug

Jiuzhitang Co., Ltd Announces Clinical Clearance for Volagidemab in Type 1 Diabetes

Fineline Cube Nov 4, 2024

China-based traditional Chinese medicine (TCM) giant Jiuzhitang Co., Ltd (SHE: 000989) has announced that volagidemab...

Company Deals

Zhaoke BRIMOCHOL-PF Taiwan License Targets Presbyopia Market

Company Drug

Kexing GB10 nAMD Injection Secures NMPA Clinical Trial Approval

Company Drug

Ignis Therapeutics Cenobamate NMPA Approval Targets Epilepsy

Company Drug

Ignis Therapeutics Solriamfetol NMPA Approval Targets OSA Sleepiness